Sutro Biopharma Inc. (STRO) Misses Q1 EPS by 294c
Tweet
Share
E-mailGet Alerts STRO Hot Sheet
Join SI Premium – FREE
Sutro Biopharma Inc. (NASDAQ: STRO) reported Q1 EPS of ($2.94). Revenue for the quarter came in at $14.52 million.
For earnings history and earnings-related data on Sutro Biopharma Inc. (STRO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
- Macquarie Downgrades Luk Fook Holdings International Ltd. (590:HK) (LKFLF) to Neutral
- Deutsche Bank Downgrades Synaptics (SYNA) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
